Volume 35 Number 4 July 23-30, 2015
Cancer
Brave-ish new world-what's needed to make precision oncology a practical reality.
MacConaill LE et al. JAMA Oncol 2015 Jul 16.
MacConaill LE et al. JAMA Oncol 2015 Jul 16.
Feasibility of large-scale genomic testing to facilitate enrollment onto genomically matched clinical trials.
Meric-Bernstam F et al. J. Clin. Oncol. 2015 May 26.
Meric-Bernstam F et al. J. Clin. Oncol. 2015 May 26.
Genetic test reporting enhances understanding of risk information and acceptance of prevention recommendations compared to family history-based counseling alone.
Taber JM et al. J Behav Med 2015 Jul 16.
Taber JM et al. J Behav Med 2015 Jul 16.
High prevalence of hereditary cancer syndromes in adolescents and young adults with colorectal cancer
Mork ME, et al. Journal of Clinical Oncology July 20, 2015
Mork ME, et al. Journal of Clinical Oncology July 20, 2015
The gynecological surveillance of women with Lynch syndrome in Sweden.
Tzortzatos G et al. Gynecol. Oncol. 2015 Jul 12.
Tzortzatos G et al. Gynecol. Oncol. 2015 Jul 12.
Treatment decision making and genetic testing for breast cancer: mainstreaming mutations
Katz S, et al. JAMA 2015 July 23
Katz S, et al. JAMA 2015 July 23
Tumor genetic screening programs: A call to action.
Hyman DM et al. J. Clin. Oncol. 2015 Jul 20.
Hyman DM et al. J. Clin. Oncol. 2015 Jul 20.
[2014 update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France].
Penault-Llorca F et al. Ann Pathol 2014 Oct 34(5) 352-65
Penault-Llorca F et al. Ann Pathol 2014 Oct 34(5) 352-65
No hay comentarios:
Publicar un comentario